CELYAD ONCOLOGY Trademark

Trademark Overview


On Thursday, October 15, 2020, a trademark application was filed for CELYAD ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the CELYAD ONCOLOGY trademark a serial number of 79298417. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by Celyad Oncology, Société anonyme. The CELYAD ONCOLOGY trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Cellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; implants comprised of living tissues, for pharmaceutical use; pharmaceutical products, namely, products for the treatment of tumors and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use; compositions comprised of white blood cells, specifically T-cells and NK-cells, for pharmaceutical use; viral vectors in the nature of biological cultures for medical use; plasmids in the nature of DNA molecules for medical use

Bioreactors for medical analysis; apparatus for culture, proliferation and modification of human cells for medical purposes; apparatus for cell therapy; catheters; surgical and medical instruments for use in the diagnosis and treatment of oncology and cardio-vascular diseases; medical implants consisting of artificial materials

Scientific and technological services, namely, research, analysis and testing in the field of oncology and cardio-vascular diseases; scientific research services in the field of cell therapy, oncology, immuno-oncology and in the field of medical and surgical instruments
celyad oncology

General Information


Serial Number79298417
Word MarkCELYAD ONCOLOGY
Filing DateThursday, October 15, 2020
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6624226
Registration DateTuesday, January 25, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesCellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; implants comprised of living tissues, for pharmaceutical use; pharmaceutical products, namely, products for the treatment of tumors and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use; compositions comprised of white blood cells, specifically T-cells and NK-cells, for pharmaceutical use; viral vectors in the nature of biological cultures for medical use; plasmids in the nature of DNA molecules for medical use
Indication of Colors claimedThe colors dark blue, gray, dark turquoise, turquoise, dark purple, purple, pink, dark maroon, maroon, red, and orange are claimed as a feature of the mark.
Description of MarkThe mark consists of the dark blue stylized wording "CELYAD ONCOLOGY" appearing to the right of four translucent overlapping semi-circles forming a spiral; the bottom semi-circle is gray; the next overlapping semi-circle is dark turquoise and turquoise; the next overlapping semi-circle is dark purple, purple and pink; the last and top overlapping semi-circle is dark maroon, maroon, red and orange.
Goods and ServicesBioreactors for medical analysis; apparatus for culture, proliferation and modification of human cells for medical purposes; apparatus for cell therapy; catheters; surgical and medical instruments for use in the diagnosis and treatment of oncology and cardio-vascular diseases; medical implants consisting of artificial materials
NOT AVAILABLE"ONCOLOGY"
Goods and ServicesScientific and technological services, namely, research, analysis and testing in the field of oncology and cardio-vascular diseases; scientific research services in the field of cell therapy, oncology, immuno-oncology and in the field of medical and surgical instruments

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, November 30, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 30, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelyad Oncology, Société anonyme
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Party NameCelyad Oncology, Société anonyme
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Party NameCelyad Oncology, Société anonyme
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Thursday, November 26, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 4, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, March 16, 2021ASSIGNED TO EXAMINER
Friday, March 19, 2021NON-FINAL ACTION WRITTEN
Saturday, March 20, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 24, 2021REFUSAL PROCESSED BY MPU
Wednesday, March 24, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 13, 2021REFUSAL PROCESSED BY IB
Tuesday, September 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 1, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, October 1, 2021EXAMINERS AMENDMENT E-MAILED
Friday, October 1, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 1, 2021EXAMINER'S AMENDMENT ENTERED
Friday, October 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Monday, April 25, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 1, 2022FINAL DISPOSITION PROCESSED
Friday, July 1, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 25, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 13, 2025NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 21, 2025NEW REPRESENTATIVE AT IB RECEIVED